X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1357) 1357
Publication (61) 61
Conference Proceeding (8) 8
Patent (5) 5
Book Chapter (4) 4
Book / eBook (3) 3
Book Review (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (670) 670
male (367) 367
female (337) 337
middle aged (292) 292
adult (291) 291
hematology (244) 244
aged (241) 241
index medicus (236) 236
oncology (174) 174
adolescent (109) 109
aged, 80 and over (106) 106
prognosis (94) 94
pathology (75) 75
treatment outcome (69) 69
risk factors (65) 65
non-hodgkins-lymphoma (63) 63
cardiac & cardiovascular systems (62) 62
cancer (61) 61
animals (59) 59
immunology (58) 58
follow-up studies (56) 56
expression (55) 55
retrospective studies (54) 54
survival (52) 52
chemotherapy (51) 51
surgery (51) 51
immunohistochemistry (49) 49
antineoplastic combined chemotherapy protocols - therapeutic use (47) 47
translocation, genetic (46) 46
classification (44) 44
survival analysis (44) 44
transplantation (44) 44
analysis (43) 43
therapy (42) 42
neoplasm staging (40) 40
child (39) 39
time factors (39) 39
disease (38) 38
lymphoma, non-hodgkin - pathology (38) 38
lymphomas (38) 38
abridged index medicus (37) 37
diagnosis (37) 37
lymphoma (37) 37
clinical neurology (36) 36
medicine, general & internal (36) 36
mutation (36) 36
care and treatment (35) 35
bone marrow - pathology (34) 34
prospective studies (34) 34
immunophenotyping (33) 33
lymphoma, b-cell - genetics (33) 33
young adult (33) 33
cohort studies (32) 32
leukemia (32) 32
research (31) 31
cell biology (30) 30
in situ hybridization, fluorescence (29) 29
combined modality therapy (28) 28
gene expression (28) 28
health aspects (28) 28
non-hodgkin's lymphoma (28) 28
remission induction (28) 28
risk (28) 28
child, preschool (27) 27
mantle cell lymphoma (27) 27
follicular lymphoma (26) 26
lymph nodes - pathology (26) 26
patients (26) 26
survival rate (26) 26
hemic and lymphatic diseases (25) 25
lymphoma, large b-cell, diffuse - genetics (25) 25
medicine, research & experimental (25) 25
mice (25) 25
registries (25) 25
research article (25) 25
respiratory system (25) 25
bone marrow (24) 24
diagnosis, differential (24) 24
peripheral vascular disease (24) 24
base sequence (23) 23
disease-free survival (23) 23
gene (23) 23
lymphoma, follicular - genetics (23) 23
medicine & public health (23) 23
netherlands - epidemiology (23) 23
antineoplastic agents - therapeutic use (21) 21
b-cell lymphoma (21) 21
biopsy (21) 21
cells, cultured (21) 21
chromosomes, human, pair 14 (21) 21
chronic lymphocytic-leukemia (21) 21
flow cytometry (21) 21
immunoglobulin heavy chains - genetics (21) 21
lymphoma, non-hodgkin - genetics (21) 21
molecular sequence data (21) 21
prednisone - administration & dosage (21) 21
radiotherapy (21) 21
rituximab (21) 21
t-lymphocytes - immunology (21) 21
tumors (21) 21
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 6, pp. 520 - 531
This international prospective study showed that maintenance therapy with rituximab was more effective than interferon alfa in prolonging the duration of... 
FCM | MEDICINE, GENERAL & INTERNAL | THERAPY | PROSPECTIVE RANDOMIZED-TRIAL | CYCLOPHOSPHAMIDE | PROGRESSION-FREE SURVIVAL | RITUXIMAB | CHRONIC LYMPHOCYTIC-LEUKEMIA | COMBINATION | FLUDARABINE | STUDY-GROUP GLSG | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Lymphoma, Mantle-Cell - mortality | Aged, 80 and over | Female | Maintenance Chemotherapy | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Survival Rate | Vidarabine - analogs & derivatives | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Vidarabine - administration & dosage | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Drugs | Dose-response relationship (Biochemistry) | Care and treatment | Fludarabine | Mantle cell lymphoma | Aged patients | Dosage and administration | Product/Service Evaluations | Drug therapy | Health aspects | Clinical trials | Prednisone | Lymphoma | Doxorubicin | Patients | Vincristine | α-Interferon | Cyclophosphamide | Motivation | Remission | Lymphomas | Computer centers | Age | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 22, pp. 2074 - 2084
Journal Article
Scientific Reports, ISSN 2045-2322, 2016, Volume 6, Issue 1, pp. 18517 - 18517
Journal Article
Leukemia, ISSN 0887-6924, 2007, Volume 21, Issue 2, pp. 207 - 214
Journal Article
Journal of pathology, ISSN 0022-3417, 2013, Volume 230, Issue 3, pp. 270 - 276
Journal Article